Table 1 |
|
|
Background characteristics of the patients (n = 64) |
|
| Gender, male (n) |
52 |
| Age, mean (± SD) |
29.9 ± 7 |
| Duration of heroin use (month) mean ± SDa |
72.2 ± 94.2 |
| Buprenorphine treatment (days) mean ± SD |
63.3 ± 363 |
| Subutex mean daily treatment dose (mg) ± SD |
22.9 ± 5.4 |
|
|
|
|
a59 patients reported history of heroin use |
|
|
Simojoki et al. Substance Abuse Treatment, Prevention, and Policy 2008 3:16 doi:10.1186/1747-597X-3-16 |
|
